Table 2.
Variables | NCPP (n = 1,027) | IP (n = 1,140) | P* |
---|---|---|---|
WBC# (×109/L) | 5.45 (4.46–7.17) | 6.14 (4.66–8.24) | < 0.001 |
NEUT% (%) | 67.5 (59.3–76.6) | 68.9 (59.4–77.7) | 0.197 |
NEUT# (×109/L) | 3.68 (2.68–5.16) | 4.09 (2.85–6.11) | < 0.001 |
LYMPH% (%) | 22.0 (14.6–29.4) | 20.5 (13.3–28.6) | 0.009 |
LYMPH# (×109/L) | 1.15 (0.83–1.51) | 1.17 (0.83–1.56) | 0.279 |
MONO% (%) | 8.5 (6.3–11.0) | 8.5 (6.5–11.1) | 0.544 |
MONO# (×109/L) | 0.47 (0.34–0.61) | 0.52 (0.37–0.69) | < 0.001 |
EO% (%) | 0.2 (0.0–2.9) | 0.3 (0.0–1.2) | < 0.001 |
EO# (×109/L) | 0.01 (0.00–0.05) | 0.02 (0.00–0.07) | < 0.001 |
BASO% (%) | 0.2 (0.0–0.3) | 0.2 (0.1–0.3) | < 0.001 |
BASO# (×109/L) | 0.01 (0.00–0.02) | 0.01 (0.01–0.02) | < 0.001 |
RBC# (×1012/L) | 4.43 (4.00–4.84) | 4.37 (3.96–4.78) | 0.012 |
HGB (g/L) | 134 (122–146) | 131 (119–143) | < 0.001 |
HCT (%) | 39.7 (36.2–43.1) | 39.1 (35.5–42.4) | 0.002 |
MCV (fL) | 89.1 (86.4–91.7) | 89.6 (86.7–92.4) | 0.003 |
MCH (pg) | 30.6 (29.5–31.6) | 30.4 (29.3–31.3) | 0.002 |
MCHC (g/L) | 343 (335–351) | 337 (329–346) | < 0.001 |
RDW-CV | 12.2 (11.9–12.8) | 12.5 (12.0–13.2) | < 0.001 |
RDW-SD (fL) | 39.5 (37.8–41.8) | 40.9 (38.8–43.2) | < 0.001 |
PLT# (×109/L) | 195 (152–248) | 198 (156–248) | 0.421 |
PDW (fL) | 12.0 (10.8–13.6) | 12.3 (11.0–13.9) | 0.021 |
MPV (fL) | 10.6 (10.0–11.3) | 10.6 (10.0–11.4) | 0.452 |
PLCR (%) | 29.5 (24.5–35.1) | 29.6 (24.9–36.0) | 0.254 |
THR (%) | 0.21 (0.17–0.26) | 0.21 (0.17–0.26) | 0.328 |
NCPP, novel coronavirus pneumonia patients; IP, Influenza patients; WBC#, white blood cell count; NEUT%, neutrophil percentage; NEUT#, neutrophil count; LYMPH%, lymphocyte percentage; LYMPH#, lymphocyte count; MONO%, monocyte percentage; MONO#, monocyte count; EO%, eosinophil percentage; EO#, eosinophil count; BASO%, basophil percentage; BASO#, basophil count; RBC#, red blood cell count; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW-CV, coefficient variation of red blood cell volume distribution width; RDW-SD, standard deviation in red cell distribution width; PLT#, platelet count; PDW, platelet distribution width; MPV, mean platelet volume; PLCR, platelet larger cell ratio; THR, thrombocytocrit
Data were presented as medians (25th–75th percentages)
Comparisons were performed between NCPP and IP groups using Mann-Whitney U test